<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34310943</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2430</ISSN><JournalIssue CitedMedium="Internet"><Volume>345</Volume><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Experimental neurology</Title><ISOAbbreviation>Exp Neurol</ISOAbbreviation></Journal><ArticleTitle>Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS.</ArticleTitle><Pagination><StartPage>113815</StartPage><MedlinePgn>113815</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.expneurol.2021.113815</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0014-4886(21)00223-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease in which patients gradually become paralyzed due to loss of motor function. Many genetically inheritable mutations have been linked to ALS; however, the majority of ALS patients are considered sporadic. Therefore, there is a need for a common therapy that is effective for all ALS patients. Although there is evidence of the disease beginning in the periphery at the neuromuscular junction (NMJ), the specific processes involved in skeletal muscle and at the NMJ are still largely unknown. To study common disease mechanisms in ALS skeletal muscle, we performed RNA sequencing of skeletal myocytes differentiated from induced pluripotent stem cells (iPSCs) derived from familial ALS (with C9ORF72, SOD1, or TARDBP mutations) and sporadic ALS patients. Compared to healthy control lines, the myocytes from all ALS lines showed downregulation of four genes: BET1L, DCX, GPC3, and HNRNPK. We next measured the expression levels of these four genes in hind limb muscle samples from a rat model of familial ALS (SOD1<sup>G93A</sup> transgenic) and found that only the Bet1L gene, which encodes Bet1 Golgi Vesicular Membrane Trafficking Protein Like, was commonly downregulated. Bet1L protein appeared to be localized to the basal lamina of the NMJ, with decreased expression over time in SOD1<sup>G93A</sup> transgenic rats. Importantly, the expression levels began to decrease early in the disease process. Our results indicate that loss of Bet1L at the NMJ could be of interest for better understanding ALS disease progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Eileen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>FitzGibbons</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Switalski</LastName><ForeName>Colton</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckardt</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tey</LastName><ForeName>Sin-Ruow</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, WI, USA; Stem Cell and Regenerative Medicine Center, University of Wisconsin-Madison, WI, USA. Electronic address: masatoshi.suzuki@wisc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR077191</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS091540</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Neurol</MedlineTA><NlmUniqueID>0370712</NlmUniqueID><ISSNLinking>0014-4886</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C107588">BET1L protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050767">Qc-SNARE Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050767" MajorTopicYN="N">Qc-SNARE Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Bet1L</Keyword><Keyword MajorTopicYN="N">Familial</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">SOD1(G93A) transgenic rat</Keyword><Keyword MajorTopicYN="N">Sporadic</Keyword></KeywordList><CoiStatement>Declarations of interest. The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34310943</ArticleId><ArticleId IdType="mid">NIHMS1729356</ArticleId><ArticleId IdType="pmc">PMC8429236</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2021.113815</ArticleId><ArticleId IdType="pii">S0014-4886(21)00223-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corcia P, Couratier P, Blasco H, et al.Genetics of amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173(5):254&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377(16):1602.</Citation><ArticleIdList><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin Pharmacother. 2017;18(7):735&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin H, Rath J, Fuzi J, et al.Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology. 2015;44(1):6&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">25571962</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T, Hermanova Z, Tureckova J, Vanatko O, Anderova AM. Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. J Clin Med. 2020;9(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovden H, Frederiksen JL, Pedersen SW. Immune system alterations in amyotrophic lateral sclerosis. Acta Neurol Scand. 2013;128(5):287&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">23550891</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De Aguilar JL. The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26(2):227&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Rossi D, Berardinelli A, Cereda C. Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol Neurobiol. 2014;49(2):984&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">24198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch E, Semrad T, Belsito VS, et al.C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells. Dis Model Mech. 2019;12(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6737948</ArticleId><ArticleId IdType="pubmed">31439573</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, et al.Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185(2):232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci. 2014;8:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakora D, Macrander C, Suzuki M. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol Res Int. 2012;2012:379657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3423938</ArticleId><ArticleId IdType="pubmed">22919482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Vodyanik MA, Smuga-Otto K, et al.Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">18029452</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Tanabe K, Ohnuki M, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Oikonomopoulos A, Sayed N, Wu JC. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development. 2018;145(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5868991</ArticleId><ArticleId IdType="pubmed">29519889</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, Tork C, Shelley B, et al.Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler. 2007;8(1):20&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17364431</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, Liu J, She Y, et al.Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A. 2002;99(3):1604&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp Neurol. 2016;277:275&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakora D, Mulcrone P, Meyer M, et al.Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther. 2013;21(8):1602&#x2013;1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3734670</ArticleId><ArticleId IdType="pubmed">23712039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3(8):637&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">16862139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig TE, Levenstein ME, Jones JM, et al.Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006;24(2):185&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">16388305</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl Med. 2014;3(5):564&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006483</ArticleId><ArticleId IdType="pubmed">24657962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiwlawat S, Lynch E, Glaser J, et al.Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture. Differentiation. 2017;96:70&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669825</ArticleId><ArticleId IdType="pubmed">28915407</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SM, Behrstock S, McHugh J, et al.GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther. 2005;16(4):509&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">15871682</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, McHugh J, Tork C, et al.Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther. 2008;16(12):2002&#x2013;2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678899</ArticleId><ArticleId IdType="pubmed">18797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, McHugh J, Tork C, et al.GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One. 2007;2(8):e689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1925150</ArticleId><ArticleId IdType="pubmed">17668067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes-Punzo A, Mulcrone P, Meyer M, McHugh J, Svendsen CN, Suzuki M. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(3):311&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644484</ArticleId><ArticleId IdType="pubmed">22409357</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783230</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Wong SH, Zhang T, Subramaniam VN, Hong W. GS15, a 15-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) homologous to rbet1. J Biol Chem. 1997;272(32):20162&#x2013;20166.</Citation><ArticleIdList><ArticleId IdType="pubmed">9242691</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Martin S, James DE, Hong W. GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is implicated in traffic in the early cisternae of the Golgi apparatus. Mol Biol Cell. 2002;13(10):3493&#x2013;3507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129961</ArticleId><ArticleId IdType="pubmed">12388752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai G, Lu L, Wang TL, et al.Participation of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex in transport from the early/recycling endosome to the trans-Golgi network. Mol Biol Cell. 2004;15(9):4011&#x2013;4022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC515336</ArticleId><ArticleId IdType="pubmed">15215310</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis F, Koulakoff A, Boucher D, et al.Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 1999;23(2):247&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">10399932</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores CA, Perderiset M, Kappeler C, et al.Distinct roles of doublecortin modulating the microtubule cytoskeleton. EMBO J. 2006;25(19):4448&#x2013;4457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1590004</ArticleId><ArticleId IdType="pubmed">16957770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa R, Ma Y, Yamaguchi M, et al.Doublecortin marks a new population of transiently amplifying muscle progenitor cells and is required for myofiber maturation during skeletal muscle regeneration. Development. 2015;142(4):810.</Citation><ArticleIdList><ArticleId IdType="pubmed">25670800</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbano M, Rastellini C, McGuire JT, et al.Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma. Cell Oncol (Dordr). 2018;41(2):169&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">29204978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Qiu H, He J, et al.The emerging roles of hnRNPK. J Cell Physiol. 2020;235(3):1995&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">31538344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollner T, Whiteheart SW, Brunner M, et al.SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993;362(6418):318&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">8455717</ArticleId></ArticleIdList></Reference><Reference><Citation>Santosa KB, Keane AM, Jablonka-Shariff A, Vannucci B, Snyder-Warwick AK. Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction. J Neurosci Res. 2018;96(7):1125&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292684</ArticleId><ArticleId IdType="pubmed">29536564</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro R, Taetzsch T, Vaughan SK, et al.Specific labeling of synaptic schwann cells reveals unique cellular and molecular features. Elife. 2020;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316509</ArticleId><ArticleId IdType="pubmed">32584256</ArticleId></ArticleIdList></Reference><Reference><Citation>Court FA, Gillingwater TH, Melrose S, et al.Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci. 2008;121(Pt 23):3901&#x2013;3911.</Citation><ArticleIdList><ArticleId IdType="pubmed">19001504</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton BL. Basal lamina and the organization of neuromuscular synapses. J Neurocytol. 2003;32(5&#x2013;8):883&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034274</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol. 1996;6(1):37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8866746</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol. 2001;152(3):435&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195998</ArticleId><ArticleId IdType="pubmed">11157973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem. 2003;278(15):12601&#x2013;12604.</Citation><ArticleIdList><ArticleId IdType="pubmed">12556454</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K, Pasterkamp RJ. Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;137(6):859&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Baker MC, Jackson JL, et al.Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol Commun. 2019;7(1):150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6781370</ArticleId><ArticleId IdType="pubmed">31594549</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, et al.The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(5&#x2013;6):432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuna S. The sciatic nerve injury model in pre-clinical research. J Neurosci Methods. 2015;243:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25629799</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotundo RL, Rossi SG, Kimbell LM, Ruiz C, Marrero E. Targeting acetylcholinesterase to the neuromuscular synapse. Chem Biol Interact. 2005;157&#x2013;158:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16289417</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi SG, Rotundo RL. Transient interactions between collagen-tailed acetylcholinesterase and sulfated proteoglycans prior to immobilization on the extracellular matrix. J Biol Chem. 1996;271(4):1979&#x2013;1987.</Citation><ArticleIdList><ArticleId IdType="pubmed">8567647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi SG, Rotundo RL. Cell surface acetylcholinesterase molecules on multinucleated myotubes are clustered over the nucleus of origin. J Cell Biol. 1992;119(6):1657&#x2013;1667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289756</ArticleId><ArticleId IdType="pubmed">1469054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiwlawat N, Lynch EM, Napiwocki BN, et al.Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes. Biotechnol Bioeng. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6699746</ArticleId><ArticleId IdType="pubmed">31131875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RA, Harrison C, Eaton SL, et al.Cellular and Molecular Anatomy of the Human Neuromuscular Junction. Cell Rep. 2017;21(9):2348&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5723673</ArticleId><ArticleId IdType="pubmed">29186674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois F, Messeant J, Kordeli E, et al.A critical and previously unsuspected role for doublecortin at the neuromuscular junction in mouse and human. Neuromuscul Disord. 2015;25(6):461&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">25817838</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi A, Emoto M, Okuya S, et al.Identification of Glypican3 as a novel GLUT4-binding protein. Biochem Biophys Res Commun. 2008;369(4):1204&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">18343214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk SE, Tracey TJ, Steyn FJ, Ngo ST. Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Front Neurol. 2019;10:191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Szaro BG. hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis. Development. 2011;138(14):3079&#x2013;3090.</Citation><ArticleIdList><ArticleId IdType="pubmed">21693523</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, James JL, Yang S, et al.Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43. Hum Mol Genet. 2015;24(6):1655&#x2013;1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">25410660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B, Mirceta M, Bomsztyk K, Macgregor RB Jr., Pearson CE. Quadruplex formation by both G-rich and C-rich DNA strands of the C9orf72 (GGGGCC)8*(GGCCCC)8 repeat: effect of CpG methylation. Nucleic Acids Res. 2015;43(20):10055&#x2013;10064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4787773</ArticleId><ArticleId IdType="pubmed">26432832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Higginbottom A, Stopford MJ, et al.Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. Acta Neuropathol. 2015;130(1):63&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, et al.C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23(13):3579&#x2013;3595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>